CMSQY 11.12   -0.100 -0.90% Updated: 07-08-2017 $CMSQY

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
42
CMSQY 11.12   -0.100 -0.90% Updated: 07-08-2017 $CMSQY
Last Trade: 7/7/2017 2:54:00 PM
Last 11.12   -0.100 -0.90%
Open 11.19
Previous Close 11.22
Day High / Low 11.19 / 11.12
Year High / Low 11.22 / 6.61
Volume 959
Projected Volume 959 (147%)
# of Trades / Projected 2 / 2
Dividend / Yield 0.00 / 0.04%
Abnormal Activity NONE
Abnormal Volume NO
Gap GAP DOWN
Candle BEARISH
Volatility Today MEDIUM
Volatility Yesterday MEDIUM
Price Relativity
From 40 Day High 99%
From 80 Day High 99%
From 150 Day High 99%
From 40 Day Low 108%
From 80 Day Low 116%
From 150 Day Low 143%
Pivot Analysis
Price Pivot $ 11.14
Day Resistance 1 $ 11.17
Day Support 1 $ 11.09
Day Resistance 2 $ 11.21
Day Support 2 $ 11.07
Consolidations
Short Term YES
Medium Term YES
Long Term YES
Volume Indicators
20 Day Avg Vol 654
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 2,615
Today / 150 Day Avg Vol BELOW
Abnormal Volume NO
William Volume Accumulation bearish
Volume Price Trend bearish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bullish
100 Day Trend bullish
Stochastics bearish
RSI bearish
MACD bullish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bullish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today MEDIUM
Volatility Index Yesterday MEDIUM
10 Day Volatility DECREASING
20 Day Volatility DECREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Updated Category News Views 88

Introduction to the Class Action Lawsuit Attention, investors! There's an important opportunity arising for shareholder litigation against Sage Therapeutics, Inc. The legal firm Bronstein, Gewirtz & Grossman, LLC is officially notifying individuals who have invested in Sage Therapeutics about a class action lawsuit that has now been filed. If you have faced substantial...

Continue Reading
FARO Technologies Revolutionizes 3D Metrology with Leap ST

Updated Category News Views 105

FARO Technologies Enhances 3D Metrology with Leap ST FARO Technologies, Inc. (NASDAQ: FARO) is pushing the boundaries of handheld scanning technology with the introduction of the Leap ST. This launch marks a significant expansion of FARO's product portfolio, positioning the company among the few firms offering a comprehensive range of portable 3D metrology solutions. Leap...

Continue Reading
Strong Financial Performance and Growth Strategies at TORM PLC

Updated Category News Views 181

TORM PLC Reports Robust Q3 2025 Financial Results TORM PLC has demonstrated remarkable resilience and adaptability, reporting its strongest quarterly results in 2025. This achievement underscores the effectiveness of TORM's integrated operating model, as highlighted by the CEO. The company continues to prioritize creating long-term value for its shareholders while...

Continue Reading
Manhattan Associates Faces Legal Challenges Amid Shareholder Losses

Updated Category News Views 304

Manhattan Associates Faces Legal Challenges Following Shareholder Loss In recent developments, Manhattan Associates, Inc. (NASDAQ: MANH) is under scrutiny as a class action lawsuit has been filed against the company. This action comes after an alarming drop in shareholder value, amounting to over $4 billion. The lawsuit is pivotal as it involves allegations of misleading...

Continue Reading
BioLife Solutions Announces Upcoming Financial Results

Updated Category News Views 91

BioLife Solutions to Share Key Financial Insights BioLife Solutions, Inc. (NASDAQ: BLFS), a pioneering developer and supplier of bioproduction products and services specializing in cell and gene therapies, is gearing up for a significant event. The company plans to release its financial results for the third quarter of 2024 after market hours on November 12, 2024. This is...

Continue Reading